(Q49144928)

18 February 2018

title

Glucose metabolism in small subcortical structures in Parkinson's disease. (English)

1 reference

18 February 2018

1 reference

1

1 reference

18 February 2018

Albert Gjedde

12

1 reference

18 February 2018

David B Keator

David Keator

11

0 references

Carsten Eggers

3

Carsten Eggers

1 reference

18 February 2018

Rüdiger Hilker

7

Rüdiger Hilker

1 reference

18 February 2018

Wolf-Dieter Heiss

8

Wolf-Dieter Heiss

1 reference

18 February 2018

Joel Aanerud

6

Joel Aanerud

1 reference

18 February 2018

Anders Rodell

9

Anders Rodell

1 reference

18 February 2018

Ole L. Munk

10

Ole L Munk

1 reference

18 February 2018

Søren B. Hansen

2

Søren B Hansen

1 reference

18 February 2018

author name string

Mallar Chakravarty

4

1 reference

18 February 2018

Kim Vang

5

1 reference

18 February 2018

language of work or name

English

0 references

publication date

21 June 2011

1 reference

18 February 2018

Acta Neurologica Scandinavica

published in

1 reference

18 February 2018

volume

125

1 reference

18 February 2018

issue

5

1 reference

18 February 2018

page(s)

303-310

1 reference

18 February 2018

Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Comparison of 3-D reconstruction with 3D-OSEM and with FORE+OSEM for PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

The creation of a brain atlas for image guided neurosurgery using serial histological data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Towards a validation of atlas warping techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Comparison of piece-wise linear, linear, and nonlinear atlas-to-patient warping techniques: analysis of the labeling of subcortical nuclei for functional neurosurgical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Subcortical elevation of metabolism in Parkinson's disease--a critical reappraisal in the context of global mean normalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

A general statistical analysis for fMRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

A unified statistical approach for determining significant signals in images of cerebral activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Network modulation in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Normalization in PET group comparison studies--the importance of a valid reference region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01556.X

10.1111/J.1600-0404.2011.01556.X

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

21692755

1 reference

18 February 2018